16 Aug
|
Boehringer Ingelheim
|
New South Wales
16 Aug
Boehringer Ingelheim
New South Wales
Boehringer Ingelheim is looking for a professional to lead the launch and commercialization of Survodutide, transforming the future of obesity and metabolic health. This opportunity entails shaping brand strategy for a pre-launch asset, with responsibilities including developing customer plans, defining value propositions, and ensuring regulatory compliance.
The ideal candidate should possess over five years in pharmaceutical brand management and a robust record of success in pre-launch or launch settings. Join us to make a significant impact on patient outcomes and lead a high-performing brand team.
#J-18808-Ljbffr
📌 Metabolic Health Brand Lead - Launch & Growth (New South Wales)
🏢 Boehringer Ingelheim
📍 New South Wales